Sight Sciences Inc. (SGHT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 2.88 |
Market Cap | 146.43M |
Revenue (ttm) | 80.20M |
Net Income (ttm) | -50.77M |
EPS (ttm) | -1.01 |
PE Ratio (ttm) | -2.86 |
Forward PE | -5.22 |
Analyst | Hold |
Ask | 2.89 |
Volume | 294,842 |
Avg. Volume (20D) | 247,091 |
Open | 2.86 |
Previous Close | 2.89 |
Day's Range | 2.81 - 2.98 |
52-Week Range | 2.67 - 8.45 |
Beta | 2.73 |
About SGHT
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthal...
Analyst Forecast
According to 7 analyst ratings, the average rating for SGHT stock is "Hold." The 12-month stock price forecast is $5.25, which is an increase of 81.98% from the latest price.
Next Earnings Release
Analysts project revenue of $20.29M, reflecting a 8.21% YoY growth and earnings per share of -0.19, making a -13.64% decrease YoY.